FibroGen Inc (FGEN)
1.045
+0.02
(+2.45%)
USD |
NASDAQ |
Apr 26, 16:00
1.045
0.00 (0.00%)
After-Hours: 17:52
FibroGen Net Income (TTM): -284.23M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -284.23M |
| September 30, 2023 | -294.18M |
| June 30, 2023 | -322.21M |
| March 31, 2023 | -307.15M |
| December 31, 2022 | -293.65M |
| September 30, 2022 | -361.56M |
| June 30, 2022 | -220.11M |
| March 31, 2022 | -281.47M |
| December 31, 2021 | -290.02M |
| September 30, 2021 | -214.58M |
| June 30, 2021 | -231.37M |
| March 31, 2021 | -182.70M |
| December 31, 2020 | -189.29M |
| September 30, 2020 | -228.78M |
| June 30, 2020 | -311.22M |
| March 31, 2020 | -109.91M |
| December 31, 2019 | -76.97M |
| September 30, 2019 | 42.11M |
| June 30, 2019 | 48.99M |
| March 31, 2019 | -90.44M |
| Date | Value |
|---|---|
| December 31, 2018 | -86.42M |
| September 30, 2018 | -141.27M |
| June 30, 2018 | -123.17M |
| March 31, 2018 | -131.66M |
| December 31, 2017 | -120.88M |
| September 30, 2017 | -117.37M |
| June 30, 2017 | -117.07M |
| March 31, 2017 | -60.84M |
| December 31, 2016 | -58.07M |
| September 30, 2016 | -79.05M |
| June 30, 2016 | -99.99M |
| March 31, 2016 | -67.25M |
| December 31, 2015 | -85.78M |
| September 30, 2015 | -84.97M |
| June 30, 2015 | -79.41M |
| March 31, 2015 | -89.63M |
| December 31, 2014 | -59.50M |
| September 30, 2014 | -35.72M |
| June 30, 2014 | 43.12M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-361.56M
Minimum
Sep 2022
48.99M
Maximum
Jun 2019
-216.23M
Average
-231.37M
Median
Jun 2021
Net Income (TTM) Benchmarks
| Emergent BioSolutions Inc | -757.20M |
| Annovis Bio Inc | -56.20M |
| Geron Corp | -184.13M |
| Regulus Therapeutics Inc | -30.04M |
| Fate Therapeutics Inc | -160.93M |